John Brendan Doyle serves as Executive at COGNITION THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, John Brendan Doyle has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 18, 2025 involved receiving (via award) 30,000 shares valued at $0.
John Brendan Doyle currently holds 455,350 shares of COGNITION THERAPEUTICS INC (CGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Brendan Doyle has been a net neutral trader of CGTX stock. They have purchased $0 and sold $0 worth of shares.
John Brendan Doyle's most recent insider trade was on Dec 18, 2025, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.50 |
| Discretionary |
| Jul 29, 2025 | CGTX | $6.3K | Payment | 9,360 | $0.67 | Discretionary |
| Jul 29, 2025 | CGTX | $0 | Award | 30,000 | $N/A | Discretionary |
| May 1, 2024 | CGTX | $17.0K | Payment | 8,699 | $1.95 | Discretionary |
| Feb 15, 2024 | CGTX | $0 | Award | 20,000 | $N/A | Discretionary |
| May 1, 2023 | CGTX | $0 | Award | 109,824 | $N/A | Discretionary |